Product Information
XULTOPHY 100 UNIT-3.6 MG/ML PEN is a brand product labeled by Novo Nordisk, priced at $85.8938 per ML under NDC 00169291115. Its NADAC has been published 445 times since Dec 20, 2017.
Strength
100; 3.6 [iU]/mL; mg/mL
Manufacturer
Novo NordiskNDC
00169291115
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN DEGLUDEC; LIRAGLUTIDEApproval Type
Biologic (BLA)
FDA Application
BLA208583On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for XULTOPHY 100 UNIT-3.6 MG/ML PEN has been published 445 times since Dec 20, 2017, and over the history we have for it it has risen 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $85.8938 per ML |
|---|---|
| All-time high | $85.9092 (Jun 10, 2026) |
| All-time low | $61.3902 (Dec 20, 2017) |
| 52-week high | $85.9092 |
| 52-week low | $85.7258 |
| Median price | $75.6902 |
| Average price | $75.1920 |
| Largest weekly change | +5.0% (Jan 11, 2023) |
| Weeks tracked | 445 |
| Tracking since | Dec 20, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the insulin degludec and liraglutide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XULTOPHY 100 UNIT-3.6 MG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for XULTOPHY 100 UNIT-3.6 MG/ML PEN, manufactured by Novo Nordisk, is $85.8938 per ML (NDC 00169291115), effective Jun 24, 2026.
How has the price of XULTOPHY 100 UNIT-3.6 MG/ML PEN changed over time?
Over the history we have for it, the NADAC for XULTOPHY 100 UNIT-3.6 MG/ML PEN has risen 39.9%. It has been tracked across 445 weekly CMS publications since Dec 20, 2017.
What are the highest and lowest recorded NADAC prices for XULTOPHY 100 UNIT-3.6 MG/ML PEN?
Since Dec 20, 2017, the NADAC for XULTOPHY 100 UNIT-3.6 MG/ML PEN has ranged from a low of $61.3902 (Dec 20, 2017) to a high of $85.9092 (Jun 10, 2026), with a median of $75.6902 per ML.
Are there cheaper alternatives to XULTOPHY 100 UNIT-3.6 MG/ML PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XULTOPHY 100 UNIT-3.6 MG/ML PEN, so no direct lower-cost alternative is listed.
Who manufactures XULTOPHY 100 UNIT-3.6 MG/ML PEN?
XULTOPHY 100 UNIT-3.6 MG/ML PEN (NDC 00169291115) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification